FIM
GSK icon

Frontier Investment Management’s GSK GSK Stock Holding History

Frontier Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,612
Closed -$266K – 283
2020
Q1 		$266K Sell
5,612
-4,525
-45% -$241K 0.02% 207
2019
Q4 		$595K Buy
10,137
+257
+3% +$14.3K 0.03% 160
2019
Q3 		$527K Buy
9,880
+3,557
+56% +$183K 0.03% 149
2019
Q2 		$316K Buy
6,323
+1,363
+27% +$68.4K 0.02% 193
2019
Q1 		$259K Sell
4,960
-400
-7% -$20K 0.02% 220
2018
Q4 		$256K Buy
5,360
+480
+10% +$23.6K 0.02% 208
2018
Q3 		$245K Sell
4,880
-80
-2% -$4.07K 0.02% 220
2018
Q2 		$250K Buy
4,960
+80
+2% +$4.03K 0.02% 206
2018
Q1 		$238K Sell
4,880
-160
-3% -$7.45K 0.02% 191
2017
Q4 		$223K Sell
5,040
-240
-5% -$11.1K 0.02% 207
2017
Q3 		$268K Hold
5,280
– – 0.02% 188
2017
Q2 		$285K Sell
5,280
-222
-4% -$11.8K 0.03% 187
2017
Q1 		$284K Buy
5,502
+222
+4% +$11.3K 0.03% 160
2016
Q4 		$254K Sell
5,280
-112
-2% -$5.53K 0.02% 170
2016
Q3 		$291K Sell
5,392
-533
-9% -$29.2K 0.03% 158
2016
Q2 		$321K Sell
5,925
-361
-6% -$19K 0.04% 153
2016
Q1 		$319K Buy
6,286
+1,056
+20% +$52.6K 0.04% 137
2015
Q4 		$264K Buy
5,230
+496
+10% +$25.3K 0.04% 134
2015
Q3 		$228K Buy
+4,734
New +$246K 0.04% 149

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Frontier Investment Management's GSK Position: Q2 2020 in Review

Frontier Investment Management sold out of GSK (GSK) in Q2 2020, closing a stake of 5,612 shares — an estimated $266K sold.

Frontier Investment Management first reported a position in GSK in Q3 2015 and held it in 19 quarters. The position peaked at $595K in Q4 2019. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Frontier Investment Management reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Frontier Investment Management sold 5,612 GSK shares in Q2 2020, an estimated $266K.
  • Frontier Investment Management first reported a position in GSK in Q3 2015 and held it in 19 quarters.
  • Frontier Investment Management's GSK position peaked at $595K in Q4 2019.
  • 841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.